SomaZoneä is a substance known as a biopolymer. It is the result of years of research in transdermal delivery.
In Entre Dermä Skincare's Night and Day Creams, active ingredients such as collagen, are attached to the SomaZoneä molecule which enables the direct delivery of these ingredients through the surface of the skin.
SomaZoneä allows large molecules to squeeze through the outer layers of skin and be delivered to where they are vitally needed. Until now, substances with a high molecular weight such as collagen, could not be reliably delivered into the skin without a needle.
ä
Transdermal Sciences Plc
Is a biopharmaceutical company focusing on the commercial applications and licensing of a patented biopolymer that is used as a non- invasive transdermal delivery system. This breakthrough technology transports high molecular weight compounds through the skin.
In order to capitalise on its huge competitive technological advantage, Transdermal Sciences is pursuing a dual strategy, targeting both the lucrative cosmetic and medical markets.
Transdermal Cosmetics Plc
Is registered in England and Wales and has been granted an exclusive worldwide license by its parent company Transdermal Sciences Plc, to exploit its unique technology in the field of cosmetics. It is common knowledge that degeneration of collagen and elastin, (both being high density molecules within the skin), can result in wrinkles.
Cosmetics Design, 3rd January 2008
Transdermal Cosmetics poised for big US launch
The maker of what is claimed to be the first ever anti-ageing cream to deliver collagen to the skin, Transdermal Cosmetics, is set to make a big launch on the US market following the company's share flotation, press reports say.
